Health in Smart Rurality: Impact on Coordination of Care of Telemonitoring and Data Centralization of Frailty Patients
NCT ID: NCT04866550
Last Updated: 2022-05-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2021-06-25
2022-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
One of the ways to reduce acute exacerbations and preserve the quality of life of patients is to detect warning signs early. One of the ways to do this is to use new communication technologies.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Telemedicine and Nursing Home
NCT02816177
Effectiveness and Organizational Conditions of Effectiveness of Telemedicine in Establishments Providing Care for the Dependent Elderly
NCT03486977
Acceptability Assessment of an "Organization of Care Integrating Artificial Intelligence and a Solution of Telemedicine" on Care of the Nursing Home Residents Located in a Medical Desert: Pilot Study INTEL@MED-POC
NCT04679181
Detection, Evaluation and Monitoring of Frailties in the Elderly (FRAGING)
NCT04992286
Remote Monitoring to Prevent Frailty Progression in the Elderly
NCT05173870
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Connected tablet
Patients aged over 60, living at home, with heart failure and / or chronic obstructive pulmonary disease, potentially requiring care cross-border (France and Belgium).
Data collection
Daily record of temperature, weight, heart rate, systolic blood pressure and oxygen saturation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Data collection
Daily record of temperature, weight, heart rate, systolic blood pressure and oxygen saturation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients living at home
* Patients with heart failure and / or chronic obstructive pulmonary disease,
* Patients potentially requiring care cross-border (France and Belgium).
* Patients agreeing to participate to the study
Exclusion Criteria
* Patients with severe cognitive impairment
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Université de Reims Champagne-Ardenne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean-Luc NOVELLA
Role: PRINCIPAL_INVESTIGATOR
Université de Reims Champagne-Ardenne - CHU de Reims
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Université de Reims Champagne-Ardenne
Reims, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jean-Luc NOVELLA
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-005-HIS2R
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.